SELPLG and plasma cell myeloma: Interaction experiments confirmed that PSGL-1 is a ligand for Siglec-7 on NK cells in multiple myeloma, and the treatment of myeloma cells with sialidase relieves the inhibition of NK cell activity and enhances the sensitivity of targeted drugs [140].